updated 9/10/2010 8:50:17 AM ET 2010-09-10T12:50:17

NEW YORK, Sept. 10, 2010 (GLOBE NEWSWIRE) -- Regenicin, Inc. (OTCBB:WDST), a clinical-stage biotechnology company, announced today that it will hold a media and investor conference at the NASDAQ MarketSite on Tuesday, September 14, 2010 at 1:00 pm EDT. CEO Randy McCoy, senior executives and board members will be present.

The conference follows Regenicin's recent announcements appointing Amgen Co-founder Dr. Joseph Rubinfeld and Pfizer's Dr. Craig Eagle as independent members of their Board of Directors.


When: September 14, 2010, 1:00 pm EDT
Where: NASDAQ MarketSite, 4 Times Square, New York, NY (43rd and Broadway)

RSVP required for building security: 212.691.2800 or strell@sunshinesachs.com


Please click here, September 14, 2010, 1:00 pm EDT http://muncmedia.stream57.com/regenicin09142010/

Mr. McCoy and his team will be available for interviews prior and post conference. Please contact Jay Strell, 212.691.2800 or strell@sunshinesachs.com 

About Regenicin ™

Regenicin, Inc. is a development-stage company focusing on next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin.  It is devoted to the discovery, development, manufacture and marketing of innovative, high-technology therapies and products for the wound care, tissue regeneration and therapeutic support system markets with PermaDerm,™ which is the only tissue-engineered skin prepared from a patient's own skin cells.  The company is headquartered in New York, NY.

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com